Bayer HealthCare drives digital innovation in healthcare

  • “Grants4Apps Accelerator” program 2015 started
  • Digital health startup companies from five countries and three continents selected
  • Bayer-intrapreneurs participate with startup company

Berlin, August 21st, 2015 – Bayer HealthCare (Bayer) fosters digital innovation in healthcare by supporting startup companies with its “Grants4Apps Accelerator 2015” program in Berlin. With the company’s support, five digital health startups from around the globe will advance their business ideas and strategies for innovative software, hardware, and technologies for doctors, patients, and consumers in the health sector. The “Grants4Apps Accelerator 2015” program is part of Bayer’s commitment to open innovation with the aim to bring innovative solutions to patients.


Today, five digital health startups officially move into the “Grants4Apps Accelerator” premises at the headquarters of the company’s pharmaceutical division in Berlin. Each of the startup companies gets financial support of up to 50,000 Euro. They will spend until late November on Bayer’s “Accelerator” premises to advance their digital health projects in areas such as hormone tests, patient adherence, breathing patterns, clinical trials and vitamin deficiency. Senior managers of Bayer and external experts will support the startups in further developing their business models during that time.


“We are excited that the ‘Grants4Apps Accelerator 2015’ program is so well accepted: The number of applications for this year’s round has tripled compared to last year,” said Johannes Schubmehl, Chief Information Officer at Bayer HealthCare. “With our ‘Accelerator’ program we create an environment in which to advance digital innovation in healthcare. We are looking forward to supporting the five digital health startups to further develop their innovative projects.”


Bayer received more than 200 digital health related applications from 48 countries to participate in the “Grants4Apps Accelerator 2015” program. Applications from Europe and the Americas were especially strongly represented, but there were also many applications from Asia, particularly from China. As a new element of the “Grants4Apps Accelerator 2015” program, Bayer employees were encouraged to found their own startup company and submit their business ideas. Senior experts from across Bayer HealthCare were involved in evaluating all applications received based on their maturity, their existing prototype and team as well as their fit to Bayer’s areas of interest.


The five digital health startups chosen for the “Grants4Apps Accelerator 2015” program come from five different countries and three continents: MediKeep OÜ from Estonia, Sendinaden Limited founded by Bayer intrapreneurs in China, Serona (a dba of Hack My Hormones, Inc.) from the Unites States of America, Viomedo UG from Germany and Vitameter Inc. from Canada. For the first time, two of the startup companies will also use the laboratory facilities in the Bayer HealthCare CoLaborator as they need further capacities to test their concepts in real life.


Forward-looking statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to confirmthem to future events or developments.